Daniel Malone obtained his B.Pharm. degree in 1994, was registered as a pharmacist in 1995, and completed his Ph.D. degree in neuropharmacology in 2000. Malone is currently a Lecturer within the Department of Pharmaceutical Biology, Monash University, Melbourne, VIC, Australia, and a part-timer pharmacist in a community pharmacy. He has over 10 years of undergraduate lecturing experience to Bachelor of Pharmacy and Bachelor of Pharmaceutical Science students. Malone is active in research into the endocannabinoid system and mental health disorders such as schizophrenia. His research focus revolves around animal models of aspects of psychosis and behavioural effects of cannabinoids. He has published 24 papers in well-respected peer-reviewed journals such as the British Journal of Pharmacology and Neuropsychopharmacology and has given a number of presentations at national and international research conferences on his research. More recently, he has had 13 publications between 2010 and March 2012; of these recent publications, 10 are related to mental health and 5 are related to cannabinoids. In total, his publications have been cited 241 times, which include 3 papers with over 30 citations (Hirsch-index = 10). He has supervised three Ph.D. students and 12 honors students (9 with 1st class Honors) to completion. He is a Member of a number of societies, including the PSA, Australian Neuroscience society (ANS), Schizophrenia International Research Society (SIRS), International Cannabinoid Research Society (ICRS), and the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists (ASCEPT). Malone is active in reviewing papers for journals including Pharmacology, Biochemistry, and Behavior and Human Psychopharmacology. He has reviewed grants for the National Health and Medical Research Council (NHMRC).
Biography Updated on 12 September 2012